Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Manon Malestroit, PhD
JCP
Original Research
Early Ketamine Response Reduces Suicidal Events at 3 Months
July 23, 2025
Patients whose suicidal ideation responded to ketamine treatment at 7 days after a suicidal crisis had 75% lower odds of experiencing suicidal events at 3 months.
Martin Pastre
,
Raphael Chancel
,
Manon Malestroit
, et al
JCP
Original Research
Suicidal Status, Inflammation, and Resting-State Activity in MDD
June 26, 2024
Resting-state activity of the VLPFC was altered in suicide attempters, possibly contributing to language impairment and poor decision-making and cognitive control.
Emilie Olié
,
Guillaume Clain
,
Manon Malestroit
, et al
